Robert Hickey

Array ( [id] => 7607744 [patent_doc_number] => 07097970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs' [patent_app_type] => utility [patent_app_number] => 09/874475 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22893 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/097/07097970.pdf [firstpage_image] =>[orig_patent_app_number] => 09874475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6649224 [patent_doc_number] => 20030104611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Feline immunodeficiency virus gene therapy vectors' [patent_app_type] => new [patent_app_number] => 09/872696 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47357 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104611.pdf [firstpage_image] =>[orig_patent_app_number] => 09872696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603665 [patent_doc_number] => 20020015707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Postinfection human immunodeficiency virus (HIV) vaccination therapy' [patent_app_type] => new [patent_app_number] => 09/872706 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26063 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015707.pdf [firstpage_image] =>[orig_patent_app_number] => 09872706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340757 [patent_doc_number] => 20020034519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Modified bovine adenovirus having altered tropism' [patent_app_type] => new [patent_app_number] => 09/871212 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 14236 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034519.pdf [firstpage_image] =>[orig_patent_app_number] => 09871212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063297 [patent_doc_number] => 20020031760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Oligonucleotides and method for detection of small round structured virus (SRSV) RNA' [patent_app_type] => new [patent_app_number] => 09/866778 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4900 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031760.pdf [firstpage_image] =>[orig_patent_app_number] => 09866778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111071 [patent_doc_number] => 20020172977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Covalent modification of abnormal prion protein' [patent_app_type] => new [patent_app_number] => 09/861306 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5590 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172977.pdf [firstpage_image] =>[orig_patent_app_number] => 09861306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356798 [patent_doc_number] => 20020058045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Adenovirus vector' [patent_app_type] => new [patent_app_number] => 09/845160 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5258 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058045.pdf [firstpage_image] =>[orig_patent_app_number] => 09845160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1179204 [patent_doc_number] => 06737067 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-18 [patent_title] => 'Trimer of HIV env gene expression product' [patent_app_type] => B1 [patent_app_number] => 09/744659 [patent_app_country] => US [patent_app_date] => 2001-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5838 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737067.pdf [firstpage_image] =>[orig_patent_app_number] => 09744659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111112 [patent_doc_number] => 20020172989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Composition and method for destruction of infectious prion proteins' [patent_app_type] => new [patent_app_number] => 09/834284 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5806 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172989.pdf [firstpage_image] =>[orig_patent_app_number] => 09834284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711121 [patent_doc_number] => 20030170870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4 positive T cells and methods of treating HIV' [patent_app_type] => new [patent_app_number] => 09/828498 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 39563 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170870.pdf [firstpage_image] =>[orig_patent_app_number] => 09828498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6948132 [patent_doc_number] => 20010021768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Sialidase localized in plasma membrane and DNA coding for the same' [patent_app_type] => new [patent_app_number] => 09/820155 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6216 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021768.pdf [firstpage_image] =>[orig_patent_app_number] => 09820155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858881 [patent_doc_number] => 20020123036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Method for analysing human immunodeficiency virus (HIV) phenotypic characteristics' [patent_app_type] => new [patent_app_number] => 09/817135 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10974 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123036.pdf [firstpage_image] =>[orig_patent_app_number] => 09817135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882621 [patent_doc_number] => 20010049093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Inhibition of viral gene activities' [patent_app_type] => new [patent_app_number] => 09/808517 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8259 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049093.pdf [firstpage_image] =>[orig_patent_app_number] => 09808517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828603 [patent_doc_number] => 20020068354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Feline immunodeficiency virus gene therapy vectors' [patent_app_type] => new [patent_app_number] => 09/797518 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 49191 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068354.pdf [firstpage_image] =>[orig_patent_app_number] => 09797518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6999901 [patent_doc_number] => 20010053368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Proteosome influenza vaccine' [patent_app_type] => new [patent_app_number] => 09/788280 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9690 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053368.pdf [firstpage_image] =>[orig_patent_app_number] => 09788280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439765 [patent_doc_number] => 06495315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Channel forming toxins as antiviral agents' [patent_app_type] => B2 [patent_app_number] => 09/758248 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 7263 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495315.pdf [firstpage_image] =>[orig_patent_app_number] => 09758248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1151440 [patent_doc_number] => 06770752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Sequences for detection of HIV-1' [patent_app_type] => B2 [patent_app_number] => 09/757207 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4801 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770752.pdf [firstpage_image] =>[orig_patent_app_number] => 09757207 [rel_patent_id] =>[rel_patent_doc_number] =>)